It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
A ground-breaking new cancer treatment, High Intensity Focused Ultrasound, (HIFU) is now available for private patients. Unlike most cancer treatments HIFU involves no surgery, has negligible side effects and requires no lengthy hospital stay.
For many years low intensity ultrasound has been used for imaging and it has been known that high power, high intensity ultrasound can affect human cells, but despite various attempts to harness this to treat cancer none have been successful.
A Consultant Surgeon at the Oxford Radcliffe Hospitals NHS Trust, a world-leading healthcare and medical training institution, said: “HIFU is a very exciting new technology that may lead to the rewriting of text books on cancer treatments in the future”.
The HAIFU System
As the first widely used equipment for extracorporeal tumour treatment with therapeutic ultrasound, the HAIFU system is a world–leading technology for the non-invasive treatment of tumours.
The Haifu System enables treatment of solid tumours using principles of surgical oncology. 3-D conformal technology allows ablation of both benign and malignant tumours. Benign tumours may be treated up to their margin, whereas malignant tumours are targeted to include specific volume of normal surrounding tissue, to ensure complete ablation.
The on-board software package allows the physician to see and capture images of the target tumour before integrating them with the therapy control system. This unique patented synthesis of programming and engineering allows the operator to image and treat from a single console, non-invasively ablating soft tissue tumours.